LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 99 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2023. The put-call ratio across all filers is 11.33 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $430,287 | -53.4% | 292,712 | +0.7% | 0.00% | – |
| Q2 2023 | $924,303 | +35.4% | 290,661 | +0.5% | 0.00% | – |
| Q1 2023 | $682,479 | +253.3% | 289,186 | +419.4% | 0.00% | – |
| Q4 2022 | $193,181 | -91.5% | 55,672 | -82.1% | 0.00% | -100.0% |
| Q3 2022 | $2,280,000 | +523.0% | 310,996 | +454.2% | 0.00% | – |
| Q2 2022 | $366,000 | +23.6% | 56,120 | -4.4% | 0.00% | – |
| Q1 2022 | $296,000 | +232.6% | 58,684 | +408.6% | 0.00% | – |
| Q4 2021 | $89,000 | – | 11,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,329,235 | $330,147,000 | 32.44% |
| Apoletto Ltd | 15,167,757 | $246,324,000 | 32.33% |
| Foresite Capital Management IV, LLC | 13,282,181 | $215,703,000 | 29.16% |
| Kirkoswald Asset Management LLC | 1,000 | $16,000 | 9.88% |
| MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC | 1,320,000 | $21,436,800,000 | 3.90% |
| HSG Holding Ltd | 2,436,798 | $39,574,000 | 2.76% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $26,761,000 | 2.50% |
| Alphabet Inc. | 5,865,125 | $95,250,000 | 1.94% |
| Arena Capital Advisors, LLC- CA | 545,137 | $8,853,000 | 0.73% |
| SB Management Ltd | 3,500,000 | $56,840,000 | 0.67% |